Dr. Vinay Yalamanchi, DO
NPI: 1538503271
Total Payments
$5,401
2024 Payments
$1,378
Companies
26
Transactions
368
Medicare Patients
4,678
Medicare Billing
$512,275
Payment Breakdown by Category
Food & Beverage$5,381 (99.6%)
Other$20.00 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,381 | 367 | 99.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $20.00 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,778 | 136 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $655.40 | 48 | $0 (2024) |
| Janssen Biotech, Inc. | $396.81 | 20 | $0 (2024) |
| Celgene Corporation | $379.94 | 23 | $0 (2024) |
| Daiichi Sankyo Inc. | $287.29 | 21 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $285.92 | 18 | $0 (2024) |
| PFIZER INC. | $257.15 | 17 | $0 (2024) |
| GENZYME CORPORATION | $204.88 | 14 | $0 (2024) |
| Gilead Sciences, Inc. | $165.75 | 11 | $0 (2024) |
| Madrigal Pharmaceuticals | $151.56 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,378 | 93 | ABBVIE INC. ($510.06) |
| 2023 | $1,506 | 99 | AbbVie Inc. ($494.38) |
| 2022 | $1,234 | 81 | ABBVIE INC. ($283.14) |
| 2021 | $906.08 | 68 | AbbVie Inc. ($320.42) |
| 2020 | $376.33 | 27 | AbbVie Inc. ($169.86) |
All Payment Transactions
368 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $12.42 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/16/2024 | ABBVIE INC. | CREON (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $20.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: Immunology | ||||||
| 12/13/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: LIVER DISEASE | ||||||
| 12/12/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: Immunology | ||||||
| 12/12/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: LIVER DISEASE | ||||||
| 12/11/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: LIVER DISEASE | ||||||
| 12/05/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/04/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: LIVER DISEASE | ||||||
| 12/04/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $2.74 | General |
| Category: LIVER DISEASE | ||||||
| 11/22/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: LIVER DISEASE | ||||||
| 11/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: Immunology | ||||||
| 11/14/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.17 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/07/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: Immunology | ||||||
| 10/30/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: Immunology | ||||||
| 10/28/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $7.41 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/26/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $3.40 | General |
| Category: LIVER DISEASE | ||||||
| 10/25/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $3.37 | General |
| Category: LIVER DISEASE | ||||||
| 10/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: Immunology | ||||||
| 10/18/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: LIVER DISEASE | ||||||
| 10/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,326 | 1,689 | $1.1M | $160,006 |
| 2022 | 14 | 1,061 | 1,242 | $583,996 | $105,641 |
| 2021 | 19 | 1,276 | 1,489 | $826,625 | $135,046 |
| 2020 | 15 | 1,015 | 1,236 | $639,538 | $111,583 |
Total Patients
4,678
Total Services
5,656
Medicare Billing
$512,275
Procedure Codes
69
All Medicare Procedures & Services
69 procedure records from CMS Medicare Utilization — Page 3 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 17 | 17 | $5,525 | $1,392 | 25.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 14 | 16 | $5,584 | $1,367 | 24.5% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 29 | 31 | $2,015 | $792.36 | 39.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 241 | 255 | $111,661 | $30,241 | 27.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 281 | 438 | $100,740 | $27,335 | 27.1% |
| 45380 | Biopsy of large bowel using an endoscope | Facility | 2020 | 59 | 61 | $110,715 | $7,690 | 6.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 37 | 38 | $19,000 | $6,640 | 34.9% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 67 | 69 | $110,055 | $6,592 | 6.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 74 | 98 | $23,030 | $5,896 | 25.6% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope | Facility | 2020 | 21 | 22 | $41,745 | $4,902 | 11.7% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 56 | 56 | $19,712 | $4,751 | 24.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 28 | 36 | $12,564 | $3,306 | 26.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 30 | 32 | $10,624 | $2,915 | 27.4% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 22 | 22 | $9,680 | $2,822 | 29.2% |
| 99305 | Initial nursing facility visit, typically 35 minutes per day | Office | 2020 | 21 | 21 | $8,795 | $2,373 | 27.0% |
| 43235 | Diagnostic examination of esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 19 | 21 | $25,410 | $2,179 | 8.6% |
| 43246 | Insertion of stomach tube using an endoscope | Facility | 2020 | 14 | 14 | $25,410 | $1,504 | 5.9% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 28 | 36 | $4,464 | $1,294 | 29.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 17 | 17 | $5,933 | $1,142 | 19.2% |
About Dr. Vinay Yalamanchi, DO
Dr. Vinay Yalamanchi, DO is a Student in an Organized Health Care Education/Training Program healthcare provider based in Bridgewater, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/24/2013. The National Provider Identifier (NPI) number assigned to this provider is 1538503271.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vinay Yalamanchi, DO has received a total of $5,401 in payments from pharmaceutical and medical device companies, with $1,378 received in 2024. These payments were reported across 368 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($5,381).
As a Medicare-enrolled provider, Yalamanchi has provided services to 4,678 Medicare beneficiaries, totaling 5,656 services with total Medicare billing of $512,275. Data is available for 4 years (2020–2023), covering 69 distinct procedure/service records.
Ad
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Gastroenterology
- Location Bridgewater, NJ
- Active Since 04/24/2013
- Last Updated 09/15/2020
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1538503271
Products in Payments
- XIFAXAN (Drug) $530.81
- HUMIRA (Biological) $415.68
- STELARA (Biological) $385.65
- ZEPOSIA (Drug) $379.94
- LINZESS (Drug) $329.77
- INJECTAFER (Drug) $287.29
- RINVOQ (Biological) $269.50
- XELJANZ (Drug) $257.15
- SKYRIZI (Biological) $241.06
- DUPIXENT (Biological) $221.95
- MAVYRET (Drug) $185.76
- CREON (Drug) $173.84
- RESMETIROM (Drug) $151.56
- VIBERZI (Drug) $149.89
- GIMOTI (Drug) $142.68
- TREMFYA (Drug) $136.15
- TRULANCE (Drug) $124.59
- IBSRELA (Drug) $109.91
- GATTEX (Drug) $108.78
- OMVOH (Drug) $98.55
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Bridgewater
Dr. Johnny Dong, Dpm, DPM
Student in an Organized Health Care Education/Training Program — Payments: $6,634
Student in an Organized Health Care Education/Training Program $6,634
Aditi Patel, Do, DO
Student in an Organized Health Care Education/Training Program — Payments: $1,379
Student in an Organized Health Care Education/Training Program $1,379
Dr. Kyle Walker, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $1,220
Student in an Organized Health Care Education/Training Program $1,220
Matthew Sallady, Do, DO
Student in an Organized Health Care Education/Training Program — Payments: $473.23
Student in an Organized Health Care Education/Training Program $473.23
Amrita De Zoysa, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $302.71
Student in an Organized Health Care Education/Training Program $302.71
Nury Yim
Student in an Organized Health Care Education/Training Program — Payments: $226.66
Student in an Organized Health Care Education/Training Program $226.66